Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pre-Menstrual Syndrome Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Analgesics (Pain Killers)
1.2.3 Oral Contraceptive Pills (OCPs)
1.2.4 Gonadotropin-Releasing Hormone (GnRH)
1.2.5 Antidepressants
1.2.6 Ovarian Suppressors
1.2.7 Diuretics
1.2.8 Benzodiazepines
1.3 Market by Application
1.3.1 Global Pre-Menstrual Syndrome Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pre-Menstrual Syndrome Market Perspective (2018-2033)
2.2 Pre-Menstrual Syndrome Growth Trends by Region
2.2.1 Global Pre-Menstrual Syndrome Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Pre-Menstrual Syndrome Historic Market Size by Region (2018-2023)
2.2.3 Pre-Menstrual Syndrome Forecasted Market Size by Region (2024-2033)
2.3 Pre-Menstrual Syndrome Market Dynamics
2.3.1 Pre-Menstrual Syndrome Industry Trends
2.3.2 Pre-Menstrual Syndrome Market Drivers
2.3.3 Pre-Menstrual Syndrome Market Challenges
2.3.4 Pre-Menstrual Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pre-Menstrual Syndrome Players by Revenue
3.1.1 Global Top Pre-Menstrual Syndrome Players by Revenue (2018-2023)
3.1.2 Global Pre-Menstrual Syndrome Revenue Market Share by Players (2018-2023)
3.2 Global Pre-Menstrual Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pre-Menstrual Syndrome Revenue
3.4 Global Pre-Menstrual Syndrome Market Concentration Ratio
3.4.1 Global Pre-Menstrual Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pre-Menstrual Syndrome Revenue in 2022
3.5 Pre-Menstrual Syndrome Key Players Head office and Area Served
3.6 Key Players Pre-Menstrual Syndrome Product Solution and Service
3.7 Date of Enter into Pre-Menstrual Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pre-Menstrual Syndrome Breakdown Data by Type
4.1 Global Pre-Menstrual Syndrome Historic Market Size by Type (2018-2023)
4.2 Global Pre-Menstrual Syndrome Forecasted Market Size by Type (2024-2033)
5 Pre-Menstrual Syndrome Breakdown Data by Application
5.1 Global Pre-Menstrual Syndrome Historic Market Size by Application (2018-2023)
5.2 Global Pre-Menstrual Syndrome Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Pre-Menstrual Syndrome Market Size (2018-2033)
6.2 North America Pre-Menstrual Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Pre-Menstrual Syndrome Market Size by Country (2018-2023)
6.4 North America Pre-Menstrual Syndrome Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pre-Menstrual Syndrome Market Size (2018-2033)
7.2 Europe Pre-Menstrual Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Pre-Menstrual Syndrome Market Size by Country (2018-2023)
7.4 Europe Pre-Menstrual Syndrome Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pre-Menstrual Syndrome Market Size (2018-2033)
8.2 Asia-Pacific Pre-Menstrual Syndrome Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Pre-Menstrual Syndrome Market Size by Region (2018-2023)
8.4 Asia-Pacific Pre-Menstrual Syndrome Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pre-Menstrual Syndrome Market Size (2018-2033)
9.2 Latin America Pre-Menstrual Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Pre-Menstrual Syndrome Market Size by Country (2018-2023)
9.4 Latin America Pre-Menstrual Syndrome Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pre-Menstrual Syndrome Market Size (2018-2033)
10.2 Middle East & Africa Pre-Menstrual Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Pre-Menstrual Syndrome Market Size by Country (2018-2023)
10.4 Middle East & Africa Pre-Menstrual Syndrome Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alva-Amco Pharmacal Cos., Inc.
11.1.1 Alva-Amco Pharmacal Cos., Inc. Company Detail
11.1.2 Alva-Amco Pharmacal Cos., Inc. Business Overview
11.1.3 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Introduction
11.1.4 Alva-Amco Pharmacal Cos., Inc. Revenue in Pre-Menstrual Syndrome Business (2018-2023)
11.1.5 Alva-Amco Pharmacal Cos., Inc. Recent Development
11.2 Bayer, Inc.
11.2.1 Bayer, Inc. Company Detail
11.2.2 Bayer, Inc. Business Overview
11.2.3 Bayer, Inc. Pre-Menstrual Syndrome Introduction
11.2.4 Bayer, Inc. Revenue in Pre-Menstrual Syndrome Business (2018-2023)
11.2.5 Bayer, Inc. Recent Development
11.3 Chattem, Inc. (Sanofi)
11.3.1 Chattem, Inc. (Sanofi) Company Detail
11.3.2 Chattem, Inc. (Sanofi) Business Overview
11.3.3 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Introduction
11.3.4 Chattem, Inc. (Sanofi) Revenue in Pre-Menstrual Syndrome Business (2018-2023)
11.3.5 Chattem, Inc. (Sanofi) Recent Development
11.4 DEKK-TEC, Inc.
11.4.1 DEKK-TEC, Inc. Company Detail
11.4.2 DEKK-TEC, Inc. Business Overview
11.4.3 DEKK-TEC, Inc. Pre-Menstrual Syndrome Introduction
11.4.4 DEKK-TEC, Inc. Revenue in Pre-Menstrual Syndrome Business (2018-2023)
11.4.5 DEKK-TEC, Inc. Recent Development
11.5 G. R. Lane Health Products Ltd
11.5.1 G. R. Lane Health Products Ltd Company Detail
11.5.2 G. R. Lane Health Products Ltd Business Overview
11.5.3 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Introduction
11.5.4 G. R. Lane Health Products Ltd Revenue in Pre-Menstrual Syndrome Business (2018-2023)
11.5.5 G. R. Lane Health Products Ltd Recent Development
11.6 McNeil Consumer Healthcare
11.6.1 McNeil Consumer Healthcare Company Detail
11.6.2 McNeil Consumer Healthcare Business Overview
11.6.3 McNeil Consumer Healthcare Pre-Menstrual Syndrome Introduction
11.6.4 McNeil Consumer Healthcare Revenue in Pre-Menstrual Syndrome Business (2018-2023)
11.6.5 McNeil Consumer Healthcare Recent Development
11.7 MetP Pharma AG
11.7.1 MetP Pharma AG Company Detail
11.7.2 MetP Pharma AG Business Overview
11.7.3 MetP Pharma AG Pre-Menstrual Syndrome Introduction
11.7.4 MetP Pharma AG Revenue in Pre-Menstrual Syndrome Business (2018-2023)
11.7.5 MetP Pharma AG Recent Development
11.8 Pherin Pharmaceuticals, Inc.
11.8.1 Pherin Pharmaceuticals, Inc. Company Detail
11.8.2 Pherin Pharmaceuticals, Inc. Business Overview
11.8.3 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Introduction
11.8.4 Pherin Pharmaceuticals, Inc. Revenue in Pre-Menstrual Syndrome Business (2018-2023)
11.8.5 Pherin Pharmaceuticals, Inc. Recent Development
11.9 Umecrine Mood AB
11.9.1 Umecrine Mood AB Company Detail
11.9.2 Umecrine Mood AB Business Overview
11.9.3 Umecrine Mood AB Pre-Menstrual Syndrome Introduction
11.9.4 Umecrine Mood AB Revenue in Pre-Menstrual Syndrome Business (2018-2023)
11.9.5 Umecrine Mood AB Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Detail
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Pre-Menstrual Syndrome Introduction
11.10.4 Novartis AG Revenue in Pre-Menstrual Syndrome Business (2018-2023)
11.10.5 Novartis AG Recent Development
11.11 GlaxoSmithKline Plc
11.11.1 GlaxoSmithKline Plc Company Detail
11.11.2 GlaxoSmithKline Plc Business Overview
11.11.3 GlaxoSmithKline Plc Pre-Menstrual Syndrome Introduction
11.11.4 GlaxoSmithKline Plc Revenue in Pre-Menstrual Syndrome Business (2018-2023)
11.11.5 GlaxoSmithKline Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pre-Menstrual Syndrome Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Analgesics (Pain Killers)
Table 3. Key Players of Oral Contraceptive Pills (OCPs)
Table 4. Key Players of Gonadotropin-Releasing Hormone (GnRH)
Table 5. Key Players of Antidepressants
Table 6. Key Players of Ovarian Suppressors
Table 7. Key Players of Diuretics
Table 8. Key Players of Benzodiazepines
Table 9. Global Pre-Menstrual Syndrome Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Pre-Menstrual Syndrome Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Pre-Menstrual Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Pre-Menstrual Syndrome Market Share by Region (2018-2023)
Table 13. Global Pre-Menstrual Syndrome Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global Pre-Menstrual Syndrome Market Share by Region (2024-2033)
Table 15. Pre-Menstrual Syndrome Market Trends
Table 16. Pre-Menstrual Syndrome Market Drivers
Table 17. Pre-Menstrual Syndrome Market Challenges
Table 18. Pre-Menstrual Syndrome Market Restraints
Table 19. Global Pre-Menstrual Syndrome Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Pre-Menstrual Syndrome Market Share by Players (2018-2023)
Table 21. Global Top Pre-Menstrual Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Menstrual Syndrome as of 2022)
Table 22. Ranking of Global Top Pre-Menstrual Syndrome Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Pre-Menstrual Syndrome Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Pre-Menstrual Syndrome Product Solution and Service
Table 26. Date of Enter into Pre-Menstrual Syndrome Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Pre-Menstrual Syndrome Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Pre-Menstrual Syndrome Revenue Market Share by Type (2018-2023)
Table 30. Global Pre-Menstrual Syndrome Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global Pre-Menstrual Syndrome Revenue Market Share by Type (2024-2033)
Table 32. Global Pre-Menstrual Syndrome Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Pre-Menstrual Syndrome Revenue Market Share by Application (2018-2023)
Table 34. Global Pre-Menstrual Syndrome Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global Pre-Menstrual Syndrome Revenue Market Share by Application (2024-2033)
Table 36. North America Pre-Menstrual Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Pre-Menstrual Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Pre-Menstrual Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Pre-Menstrual Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. Europe Pre-Menstrual Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Pre-Menstrual Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 42. Asia-Pacific Pre-Menstrual Syndrome Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 43. Asia-Pacific Pre-Menstrual Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Pre-Menstrual Syndrome Market Size by Region (2024-2033) & (US$ Million)
Table 45. Latin America Pre-Menstrual Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Latin America Pre-Menstrual Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Pre-Menstrual Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 48. Middle East & Africa Pre-Menstrual Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Middle East & Africa Pre-Menstrual Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Pre-Menstrual Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 51. Alva-Amco Pharmacal Cos., Inc. Company Detail
Table 52. Alva-Amco Pharmacal Cos., Inc. Business Overview
Table 53. Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Product
Table 54. Alva-Amco Pharmacal Cos., Inc. Revenue in Pre-Menstrual Syndrome Business (2018-2023) & (US$ Million)
Table 55. Alva-Amco Pharmacal Cos., Inc. Recent Development
Table 56. Bayer, Inc. Company Detail
Table 57. Bayer, Inc. Business Overview
Table 58. Bayer, Inc. Pre-Menstrual Syndrome Product
Table 59. Bayer, Inc. Revenue in Pre-Menstrual Syndrome Business (2018-2023) & (US$ Million)
Table 60. Bayer, Inc. Recent Development
Table 61. Chattem, Inc. (Sanofi) Company Detail
Table 62. Chattem, Inc. (Sanofi) Business Overview
Table 63. Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Product
Table 64. Chattem, Inc. (Sanofi) Revenue in Pre-Menstrual Syndrome Business (2018-2023) & (US$ Million)
Table 65. Chattem, Inc. (Sanofi) Recent Development
Table 66. DEKK-TEC, Inc. Company Detail
Table 67. DEKK-TEC, Inc. Business Overview
Table 68. DEKK-TEC, Inc. Pre-Menstrual Syndrome Product
Table 69. DEKK-TEC, Inc. Revenue in Pre-Menstrual Syndrome Business (2018-2023) & (US$ Million)
Table 70. DEKK-TEC, Inc. Recent Development
Table 71. G. R. Lane Health Products Ltd Company Detail
Table 72. G. R. Lane Health Products Ltd Business Overview
Table 73. G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Product
Table 74. G. R. Lane Health Products Ltd Revenue in Pre-Menstrual Syndrome Business (2018-2023) & (US$ Million)
Table 75. G. R. Lane Health Products Ltd Recent Development
Table 76. McNeil Consumer Healthcare Company Detail
Table 77. McNeil Consumer Healthcare Business Overview
Table 78. McNeil Consumer Healthcare Pre-Menstrual Syndrome Product
Table 79. McNeil Consumer Healthcare Revenue in Pre-Menstrual Syndrome Business (2018-2023) & (US$ Million)
Table 80. McNeil Consumer Healthcare Recent Development
Table 81. MetP Pharma AG Company Detail
Table 82. MetP Pharma AG Business Overview
Table 83. MetP Pharma AG Pre-Menstrual Syndrome Product
Table 84. MetP Pharma AG Revenue in Pre-Menstrual Syndrome Business (2018-2023) & (US$ Million)
Table 85. MetP Pharma AG Recent Development
Table 86. Pherin Pharmaceuticals, Inc. Company Detail
Table 87. Pherin Pharmaceuticals, Inc. Business Overview
Table 88. Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Product
Table 89. Pherin Pharmaceuticals, Inc. Revenue in Pre-Menstrual Syndrome Business (2018-2023) & (US$ Million)
Table 90. Pherin Pharmaceuticals, Inc. Recent Development
Table 91. Umecrine Mood AB Company Detail
Table 92. Umecrine Mood AB Business Overview
Table 93. Umecrine Mood AB Pre-Menstrual Syndrome Product
Table 94. Umecrine Mood AB Revenue in Pre-Menstrual Syndrome Business (2018-2023) & (US$ Million)
Table 95. Umecrine Mood AB Recent Development
Table 96. Novartis AG Company Detail
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Pre-Menstrual Syndrome Product
Table 99. Novartis AG Revenue in Pre-Menstrual Syndrome Business (2018-2023) & (US$ Million)
Table 100. Novartis AG Recent Development
Table 101. GlaxoSmithKline Plc Company Detail
Table 102. GlaxoSmithKline Plc Business Overview
Table 103. GlaxoSmithKline Plc Pre-Menstrual Syndrome Product
Table 104. GlaxoSmithKline Plc Revenue in Pre-Menstrual Syndrome Business (2018-2023) & (US$ Million)
Table 105. GlaxoSmithKline Plc Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pre-Menstrual Syndrome Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Pre-Menstrual Syndrome Market Share by Type: 2022 VS 2033
Figure 3. Analgesics (Pain Killers) Features
Figure 4. Oral Contraceptive Pills (OCPs) Features
Figure 5. Gonadotropin-Releasing Hormone (GnRH) Features
Figure 6. Antidepressants Features
Figure 7. Ovarian Suppressors Features
Figure 8. Diuretics Features
Figure 9. Benzodiazepines Features
Figure 10. Global Pre-Menstrual Syndrome Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 11. Global Pre-Menstrual Syndrome Market Share by Application: 2022 VS 2033
Figure 12. Hospitals Case Studies
Figure 13. Clinic Case Studies
Figure 14. Others Case Studies
Figure 15. Pre-Menstrual Syndrome Report Years Considered
Figure 16. Global Pre-Menstrual Syndrome Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Pre-Menstrual Syndrome Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Pre-Menstrual Syndrome Market Share by Region: 2022 VS 2033
Figure 19. Global Pre-Menstrual Syndrome Market Share by Players in 2022
Figure 20. Global Top Pre-Menstrual Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Menstrual Syndrome as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Pre-Menstrual Syndrome Revenue in 2022
Figure 22. North America Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Pre-Menstrual Syndrome Market Share by Country (2018-2033)
Figure 24. United States Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Pre-Menstrual Syndrome Market Share by Country (2018-2033)
Figure 28. Germany Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Pre-Menstrual Syndrome Market Share by Region (2018-2033)
Figure 36. China Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Pre-Menstrual Syndrome Market Share by Country (2018-2033)
Figure 44. Mexico Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Pre-Menstrual Syndrome Market Share by Country (2018-2033)
Figure 48. Turkey Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Pre-Menstrual Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Alva-Amco Pharmacal Cos., Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2018-2023)
Figure 51. Bayer, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2018-2023)
Figure 52. Chattem, Inc. (Sanofi) Revenue Growth Rate in Pre-Menstrual Syndrome Business (2018-2023)
Figure 53. DEKK-TEC, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2018-2023)
Figure 54. G. R. Lane Health Products Ltd Revenue Growth Rate in Pre-Menstrual Syndrome Business (2018-2023)
Figure 55. McNeil Consumer Healthcare Revenue Growth Rate in Pre-Menstrual Syndrome Business (2018-2023)
Figure 56. MetP Pharma AG Revenue Growth Rate in Pre-Menstrual Syndrome Business (2018-2023)
Figure 57. Pherin Pharmaceuticals, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2018-2023)
Figure 58. Umecrine Mood AB Revenue Growth Rate in Pre-Menstrual Syndrome Business (2018-2023)
Figure 59. Novartis AG Revenue Growth Rate in Pre-Menstrual Syndrome Business (2018-2023)
Figure 60. GlaxoSmithKline Plc Revenue Growth Rate in Pre-Menstrual Syndrome Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed